Severe hypocalcaemia because of osteoblastic prostate carcinoma metastases

International Journal of Clinical Practice

Volumn 62, Issue 10, 2008, Pages 1630-1631

  Yener, Serkan ^a   Demir, Omer ^a   Ozdogan, Ozhan ^a   Akinci, Baris ^a   Yesil, Sena ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BICALUTAMIDE; CALCITRIOL; CALCIUM; GOSERELIN;

BREAST CARCINOMA; CANCER RESEARCH; DISEASE SEVERITY; HUMAN; HYPOCALCEMIA; LETTER; PRIORITY JOURNAL; PROSTATE CARCINOMA;

AGED; BONE NEOPLASMS; HUMANS; HYPOCALCEMIA; MALE; PROSTATIC NEOPLASMS;

EID: 51349136155     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2008.01802.x     Document Type: Letter

References (6)

1. Blomqvist CP. A hospital survey of hypocalcemia in patients with malignant disease. Acta Med Scand 1986 220 : 167 73.
2. Fokkema MI, de Heide LJ, van Schelven WD, Hamdy NA. Severe hypocalcaemia associated with extensive osteoblastic metastases in a patient with prostate cancer. Neth J Med 2005 63 : 34 7.
3. Guise TA, Kozlow WM, Heras-Herzig A, Padalecki SS, Yin JJ, Chirgwin JM. Molecular mechanisms of breast cancer metastases to bone. Clin Breast Cancer 2005 5 (Suppl. S46 53.
4. Watanabe T, Adachi I, Kimura S et al. A case of advanced breast cancer associated with hypocalcemia. Jpn J Clin Oncol 1983 13 : 441 8.
5. Dai J, Keller J, Zhang J, Lu Y, Yao ZKeller ET. Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism. Cancer Res 2005 65 : 8274 85.
6. Berruti A, Dogliotti L, Bitossi R et al. Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline. J Urol 2000 164 : 1248 53.